Literature DB >> 28377289

Golgi trafficking defects in postnatal microcephaly: The evidence for "Golgipathies".

Sandrine Passemard1, Franck Perez2, Emilie Colin-Lemesre3, Sowmyalakshmi Rasika4, Pierre Gressens5, Vincent El Ghouzzi6.   

Abstract

The Golgi apparatus plays a central role in cell homeostasis, not only in processing and maturing newly synthesized proteins and lipids but also in orchestrating their sorting, packing, routing and recycling on the way to their final destination. These multiple secretory pathways require a complex ballet of vesicular and tubular carriers that continuously bud off from donor membranes and fuse to acceptor membranes. Membrane trafficking is particularly prominent in axons, where cargo molecules have a long way to travel before they reach the synapse, and in oligodendrocytes, which require an immense increase in membrane surface in order to sheathe axons in myelin. Interestingly, in recent years, genes encoding Golgi-associated proteins with a role in membrane trafficking have been found to be defective in an increasing number of inherited disorders whose clinical manifestations include postnatal-onset microcephaly (POM), white matter defects and intellectual disability. Several of these genes encode RAB GTPases, RAB-effectors or RAB-regulating proteins, linking POM and intellectual disability to RAB-dependent Golgi trafficking pathways and suggesting that their regulation is critical to postnatal brain maturation and function. Here, we review the key roles of the Golgi apparatus in post-mitotic neurons and the oligodendrocytes that myelinate them, and provide an overview of these Golgi-associated POM-causing genes, their function in Golgi organization and trafficking and the likely mechanisms that may link dysfunctions in RAB-dependent regulatory pathways with POM.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Golgi apparatus; Golgipathies; Intellectual disability; Neuronal trafficking; Postnatal microcephaly; RAB GTPase

Mesh:

Substances:

Year:  2017        PMID: 28377289     DOI: 10.1016/j.pneurobio.2017.03.007

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  12 in total

1.  A neurodevelopmental disorder caused by mutations in the VPS51 subunit of the GARP and EARP complexes.

Authors:  David C Gershlick; Morié Ishida; Julie R Jones; Allison Bellomo; Juan S Bonifacino; David B Everman
Journal:  Hum Mol Genet       Date:  2019-05-01       Impact factor: 6.150

Review 2.  Tied up: Does altering phosphoinositide-mediated membrane trafficking influence neurodegenerative disease phenotypes?

Authors:  Sravanthi S P Nadiminti; Madhushree Kamak; Sandhya P Koushika
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

3.  Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus.

Authors:  Lígia C Gomes-da-Silva; Liwei Zhao; Lucillia Bezu; Heng Zhou; Allan Sauvat; Peng Liu; Sylvère Durand; Marion Leduc; Sylvie Souquere; Friedemann Loos; Laura Mondragón; Baldur Sveinbjørnsson; Øystein Rekdal; Gaelle Boncompain; Franck Perez; Luis G Arnaut; Oliver Kepp; Guido Kroemer
Journal:  EMBO J       Date:  2018-05-28       Impact factor: 11.598

4.  COPB2 loss of function causes a coatopathy with osteoporosis and developmental delay.

Authors:  Ronit Marom; Lindsay C Burrage; Rossella Venditti; Aurélie Clément; Bernardo Blanco-Sánchez; Mahim Jain; Daryl A Scott; Jill A Rosenfeld; V Reid Sutton; Marwan Shinawi; Ghayda Mirzaa; Catherine DeVile; Rowenna Roberts; Alistair D Calder; Jeremy Allgrove; Ingo Grafe; Denise G Lanza; Xiaohui Li; Kyu Sang Joeng; Yi-Chien Lee; I-Wen Song; Joseph M Sliepka; Dominyka Batkovskyte; Megan Washington; Brian C Dawson; Zixue Jin; Ming-Ming Jiang; Shan Chen; Yuqing Chen; Alyssa A Tran; Lisa T Emrick; David R Murdock; Neil A Hanchard; Gladys E Zapata; Nitesh R Mehta; Mary Ann Weis; Abbey A Scott; Brenna A Tremp; Jennifer B Phillips; Jeremy Wegner; Tashunka Taylor-Miller; Richard A Gibbs; Donna M Muzny; Shalini N Jhangiani; John Hicks; Rolf W Stottmann; Mary E Dickinson; John R Seavitt; Jason D Heaney; David R Eyre; Monte Westerfield; Maria Antonietta De Matteis; Brendan Lee
Journal:  Am J Hum Genet       Date:  2021-08-26       Impact factor: 11.025

5.  Biallelic truncating variants in ATP9A cause a novel neurodevelopmental disorder involving postnatal microcephaly and failure to thrive.

Authors:  Guido Vogt; Sarah Verheyen; Sarina Schwartzmann; Nadja Ehmke; Cornelia Potratz; Anette Schwerin-Nagel; Barbara Plecko; Manuel Holtgrewe; Dominik Seelow; Jasmin Blatterer; Michael R Speicher; Uwe Kornak; Denise Horn; Stefan Mundlos; Björn Fischer-Zirnsak; Felix Boschann
Journal:  J Med Genet       Date:  2021-06-18       Impact factor: 5.941

6.  AP4B1-associated hereditary spastic paraplegia: expansion of phenotypic spectrum related to homozygous p.Thr387fs variant.

Authors:  Krzysztof Szczałuba; Hanna Mierzewska; Robert Śmigiel; Joanna Kosińska; Agnieszka Koppolu; Anna Biernacka; Piotr Stawiński; Agnieszka Pollak; Małgorzata Rydzanicz; Rafał Płoski
Journal:  J Appl Genet       Date:  2020-03-12       Impact factor: 3.240

7.  Biallelic variants in TRAPPC10 cause a microcephalic TRAPPopathy disorder in humans and mice.

Authors:  Lettie E Rawlins; Hashem Almousa; Shazia Khan; Stephan C Collins; Miroslav P Milev; Joseph Leslie; Djenann Saint-Dic; Valeed Khan; Ana Maria Hincapie; Jacob O Day; Lucy McGavin; Christine Rowley; Gaurav V Harlalka; Valerie E Vancollie; Wasim Ahmad; Christopher J Lelliott; Asma Gul; Binnaz Yalcin; Andrew H Crosby; Michael Sacher; Emma L Baple
Journal:  PLoS Genet       Date:  2022-03-17       Impact factor: 5.917

Review 8.  Cortical Organoids to Model Microcephaly.

Authors:  Sarah Farcy; Alexandra Albert; Pierre Gressens; Alexandre D Baffet; Vincent El Ghouzzi
Journal:  Cells       Date:  2022-07-07       Impact factor: 7.666

9.  Mixed Neurodevelopmental and Neurodegenerative Pathology in Nhe6-Null Mouse Model of Christianson Syndrome.

Authors:  Meiyu Xu; Qing Ouyang; Jingyi Gong; Matthew F Pescosolido; Brandon S Pruett; Sasmita Mishra; Michael Schmidt; Richard N Jones; Ece D Gamsiz Uzun; Sofia B Lizarraga; Eric M Morrow
Journal:  eNeuro       Date:  2018-01-17

10.  A de novo variant in ADGRL2 suggests a novel mechanism underlying the previously undescribed association of extreme microcephaly with severely reduced sulcation and rhombencephalosynapsis.

Authors:  Myriam Vezain; Matthieu Lecuyer; Marina Rubio; Valérie Dupé; Leslie Ratié; Véronique David; Laurent Pasquier; Sylvie Odent; Sophie Coutant; Isabelle Tournier; Laetitia Trestard; Homa Adle-Biassette; Denis Vivien; Thierry Frébourg; Bruno J Gonzalez; Annie Laquerrière; Pascale Saugier-Veber
Journal:  Acta Neuropathol Commun       Date:  2018-10-19       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.